Download 10.25 CME 4th Annual CME Symposium PHYSICIANS

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Childhood immunizations in the United States wikipedia , lookup

Neonatal infection wikipedia , lookup

Infection wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

Infection control wikipedia , lookup

Hepatitis B wikipedia , lookup

Hepatitis C wikipedia , lookup

Transcript
Co-Chairs:
Raymond T. Chung, MD
Robert S. Klein, MD
John F. Reinus, MD, FACG
David L. Thomas, MD, MPH
Faculty:
Arthur Y. Kim, MD, FIDSA
Jennifer J. Kiser, PharmD
Alain H. Litwin, MD, MPH
Kristen M. Marks, MD
Jorge A. Marrero, MD
Paul Martin, MD
Andrew J. Muir, MD, MHS
Susanna Naggie, MD, MHS
Marion G. Peters, MD
Stuart C. Ray, MD, FIDSA
Kenneth E. Sherman, MD, PhD
Mark S. Sulkowski, MD
John B. Wong, MD
4th Annual CME Symposium
This advanced continuing medical education activity will provide participants with state-of-the-art
education and practical guidance from internationally recognized experts on hepatitis C virus infection. Key Learning Objectives
PHYSICIANS
CME ISSUED BY
•Recognize the indications for treatment of HCV infection as well as areas of uncertainty in treatment
•Explain barriers to effective care of patients with hepatitis C
•Distinguish the recognition and treatment of acute HCV infection from that of chronic infection
•Apply new information to manage disease in difficult-to-treat populations
•Indicate new therapeutic drugs, pharmacology of HCV therapy, and resistance to treatments
•Demonstrate the approach to diagnosis and treatment of hepatocellular carcinoma
ALBERT EINSTEIN
COLLEGE OF MEDICINE
OF YESHIVA UNIVERSITY
Albert Einstein College of Medicine of Yeshiva
Target Audience
University is accredited by the Accreditation
This activity is designed for hepatologists, gastroenterologists, infectious disease specialists, nurse
practitioners, and other frontline allied healthcare professionals involved in management of patients
with hepatitis C and HCV/HIV coinfection.
Council for Continuing Medical Education to
provide continuing medical education for
physicians. Albert Einstein College of Medicine
designates this live educational activity for
Registration & Fees
a maximum of 10.25 AMA PRA Category 1
HEP Registration by 12/31/14............................................................................... $295
AECOM & Residents/Fellows............................................................................. $245
SAVE — Register for both HEPATITIS C MANAGEMENT - STATE OF THE ART
& HIV Management 2015: THE NEW YORK COURSE by 12/31/14......................................$595
For more information or to register, visit
10.25 CME
credits™. Physicians should only claim credit
commensurate with the extent of their
participation in the activity. This activity was
planned and produced in accordance with the
Requirements of the ACCME.
www.hep2015.com or call 888-391-3996